Beatrice U. Mueller

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia

Thomas Pabst, Beatrice U. Mueller, Pu Zhang et al. · Nature Genetics · 2001 · 903 citations

Hematological Malignancy, Tumor Biology, Transcriptional Regulation +10

AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia

Thomas Pabst, Beatrice U. Mueller, Nari Harakawa et al. · Nature Medicine · 2001 · 462 citations

Hematological Malignancy, Hematology, Immunology +8

PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding

Pu Zhang, Xiaobo Zhang, Atsushi Iwama et al. · Blood · 2000 · 358 citations

Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)

U. Gatzemeier, A Płużańska, A. Szczęsna et al. · Journal of Clinical Oncology · 2004 · 300 citations

Advanced Nsclc, Oncology, Medicine +14

Heterozygous PU.1 mutations are associated with acute myeloid leukemia

Beatrice U. Mueller, Thomas Pabst, Motomi Osato et al. · Blood · 2002 · 239 citations · Full text